Author Question: Following release from the presynaptic cell, neuropeptides a. cannot be deactivated by enzymes, ... (Read 15 times)

ENagel

  • Hero Member
  • *****
  • Posts: 540
Following release from the presynaptic cell, neuropeptides
 
  a. cannot be deactivated by enzymes, whereas small-molecule transmitters diffuse away or are deactivated by reuptake.
  b. are deactivated by reuptake, whereas small-molecule transmitters diffuse away or are deactivated by enzymes.
  c. can diffuse away from synapses, whereas small-molecule transmitters are deactivated by reuptake.
 d. and small-molecule transmitters can be deactivated by diffusion, enzymes, or reuptake.

Question 2

The release of vesicles containing neuropeptides requires
 
  a. higher levels of calcium than the release of small-molecule neurotransmitters.
 b. lower levels of calcium than the release of small-molecule neurotransmitters.
 c. approximately equal levels of calcium as the release of small-molecule neurotransmitters.
  d. no calcium at all.



leannegxo

  • Sr. Member
  • ****
  • Posts: 374
Answer to Question 1

c

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

For a complete list of videos, visit our video library